|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.1 USD | +3.68% |
|
-4.02% | -3.73% |
| Mar. 08 | Ovid Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 08 | Earnings Flash (OVID) OVID THERAPEUTICS Reports Q4 Revenue $141,562 | MT |
Ovid Therapeutics Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported revenue was USD 0.141562 million compared to USD 0.04628 million a year ago. Net loss was USD 15.32 million compared to USD 11.5 million a year ago.
Basic loss per share from continuing operations was USD 0.22 compared to USD 0.16 a year ago. Diluted loss per share from continuing operations was USD 0.22 compared to USD 0.16 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -3.73% | 220M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
OVID THERAPEUTICS INC. 
